Hope Begins Here With Spravato®
SPRAVATO® (esketamine) nasal spray is the first FDA-approved therapy for depression.
What is SPRAVATO®?
Spravato® is an FDA-approved nasal spray designed for adults with treatment-resistant depression or major depression with suicidal thoughts.
Relief can come within days as opposed to months.
Spravato® is designed to treat
Treatment-Resistant Depression
Severe depression and suicidal ideation
Affordable. Effective. Covered.
FDA-approved and effective
Insurance covers your visit
Medication costs as low as $10
Insurance Accepted
Select Health Signature plan is not covered
What to expect
Your care journey with us is supportive, thorough, and always personalized:
Meet & Evaluate
Schedule your first visit, complete consent and intake paperwork, and talk with one of our psychiatric providers to see if Spravato® is a good fit for your needs.
Insurance & Approval
If you’ve tried two or more antidepressants without success, we’ll help you through the insurance approval process so you can focus on healing.
Begin Treatment
Start your in‑office Spravato® sessions in a safe, comfortable setting with our team by your side, including observation and ongoing follow‑up to track your progress.
Patient Videos
Meet Your Providers
Jamie Binks
Psychiatry, APRN, PMHNP
Psychiatry, APRN, PMHNP
Regan Haight
Want to Learn More About Spravato®?
Curious how Spravato® works in your body and what to expect during your appointment?
Watch this short video to get all the details and feel confident about your next steps.
FAQ
-
No. Spravato® contains esketamine, a related but distinct medication, approved specifically for depression and delivered as a nasal spray.
-
For some patients, ketamine injections may provide faster or stronger relief than Spravato®. However, Spravato® is FDA-approved and often covered by insurance, making it a convenient and accessible option. Effectiveness varies between individuals, so we’ll work with you to find the best treatment for your needs.
-
Some patients experience a calm, relaxed feeling during treatment. You’ll be comfortably monitored for two hours afterward before going home.
-
Yes. Spravato® is usually combined with an oral antidepressant. Your provider ensures it’s safe with your current medications.
-
Treatment usually starts with twice-weekly sessions for one month, then shifts to once a week for the next month. Many patients experience significant improvements and feel ready to graduate at that time.
-
Many insurance plans cover Spravato®. Our team helps manage insurance approval to ease your path.
-
Driving after treatment isn’t allowed. You can arrange safe rides through Uber Health if needed.
-
Spravato® is not considered addictive when used as prescribed under medical supervision. Your treatment is carefully monitored by our team to ensure your safety and well-being throughout the process.